Cefixime recalls
The FDA has published 7 recalls involving Cefixime since 2020. The latest was reported on 4 Sep 2024. Most were for potency & assay. Lupin Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls7since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 4 Sep 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 7 100%Class III 0 0%
Why cefixime is recalled
Companies
By year
All cefixime recalls, newest first
7 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Cefixime for Oral Suspension USP, 100 mg recalledCefixime | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Cefixime for Oral Suspension USP 200 mg/ Pack size) recalledCefixime | Lupin Pharmaceuticals | Other | Nationwide |
| Drug | CLASS II | Cefixime for Oral Suspension 100mg recalled by Lupin PharmaceuticalsCefixime | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Cefixime Capsules, 400 mg recalled by Ascend LaboratoriesCefixime | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Cefixime Capsules 400 mg recalled by Ascend LaboratoriesCefixime | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Cefixime for Oral Suspension USP 100 mg/ HDPE recalledCefixime | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Cefixime for Oral Suspension USP, 100mg recalledCefixime | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
Should you stop taking Cefixime?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.